Showing 45 results

Filters Content type: News, Editors' picks Topic: Antibody-based treatment
Antibody-based treatment

Broadly neutralising antibody N6LS could be part of long-acting HIV treatment

News
17 March 2025
Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies could be twice-yearly HIV treatment

News
12 March 2025
Antibody-based treatment

Half the men in an HIV cure study stayed off treatment for nearly a year after a two-antibody shot

News
12 March 2025
Antibody-based treatment

Broadly neutralizing antibody treatment found to reduce viral reservoir in some infants with HIV-1

Editor's pick
Medical Xpress
12 July 2023
Injectable & long-acting HIV treatment

Going Long

Editor's pick
POZ
26 June 2023
New & experimental HIV treatments

Top 5 stories on new drugs for HIV prevention and treatment from CROI 2023

News
14 March 2023
Injectable & long-acting HIV treatment

Lenacapavir plus broadly neutralising antibodies may offer twice-yearly treatment option

News
28 February 2023
Antibody-based treatment

Do broadly neutralising antibodies really have a future in treating HIV?

News
11 November 2022
Pharmaceutical industry

Long-suffering CytoDyn withdraws HIV approval application for leronlimab, blaming clinical research organization

Editor's pick
FierceBiotech
1 November 2022
Antibody-based treatment

GSK's ViiV gives early look at HIV broadly neutralizing antibody's power, eyes long-acting combo trial

Editor's pick
FierceBiotech
28 October 2022
Antibody-based treatment

ViiV Healthcare presents positive proof-of-concept findings for N6LS, an investigational, broadly neutralising antibody (bNAb) offering a potential new approach for the treatment of HIV

Editor's pick
ViiV press release
26 October 2022
The search for a cure

A cure must be a cure for all: why more HIV cure research in Africa is needed

News
22 August 2022
The search for a cure

Combination Anti-HIV Antibody Infusions Suppress Virus for Sustained Period

Editor's pick
HIV.gov
6 June 2022
Antibody-based treatment

Repeated infusions of two antibodies delay viral rebound but don’t prevent it

News
13 May 2022
The search for a cure

Antibody therapy controls HIV for months in new clinical trial

Editor's pick
The Rockerfeller University
22 April 2022
Antibody-based treatment

New approach for delivery of anti-HIV antibody therapy shows promise in phase I clinical trial

Editor's pick
EurekAlert
13 April 2022
New & experimental HIV treatments

Top 5 HIV treatment stories from CROI 2022

News
2 March 2022
The search for a cure

Top 5 HIV cure and vaccine stories from CROI 2022

News
2 March 2022
Antibody-based treatment

Broadly neutralising antibody treatment: is pre-existing resistance its Achilles heel?

News
23 February 2022
Antibody-based treatment

One person remains undetectable without HIV drugs almost four years after using an antibody-based therapy

News
16 February 2022
Antibody-based treatment

Could antibodies be used for children with HIV instead of pills?

News
14 February 2022
Antibody-based prevention

Why broadly neutralising antibodies might be the next big thing in HIV

Editor's pick
Spotlight
8 February 2021
New & experimental HIV treatments

Monoclonal antibody ibalizumab maintains HIV suppression for nearly a decade

News
29 October 2020
The search for a cure

Gene therapy or immunotherapy: which approach is more likely to deliver a cure for HIV?

News
10 July 2020